Metabolism study in CLL lymph nodes
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at how chronic lymphocytic leukemia (CLL) cells use energy in lymph nodes. It may help find new ways to treat CLL in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with CLL using blood and cell tests.
- You are 18 years or older.
- You have signed a form saying you don't object to participating.
- You have not yet had any treatment for your CLL.
- You do not have a solid cancer that is growing or that was treated less than 3 years ago.
- You do not have HIV or chronic active hepatitis B or C.
- You have never had a stem cell or bone marrow transplant from a donor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from people diagnosed with chronic lymphatic leukemia. It may help doctors better understand the disease, track patient needs, and improve future care.
This study measures how your body’s metabolism works in people with chronic lymphocytic leukemia (CLL). It uses blood tests, and for some people, a bone marrow sample, to better understand what’s happening and potentially guide future treatments.
This study tests whether a whole-food plant-based diet for 4 weeks can affect immune function and metabolism in people with early-stage CLL who have not yet had treatment.
This study looks at how changing your diet and exercise routine affects your health if you have CLL. It's testing whether a personalized energy balance plan can help you feel better and manage your disease.
This study looks at how blood cancer cells use energy (metabolism) and how that affects the immune system. Researchers hope to find new ways to treat these cancers by understanding cell metabolism better.
This study looks at how the immune system works in people with untreated CLL and tries to find ways to predict who might get infections. It aims to help doctors better protect patients from infections in the future.
Hear when a new CLL trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.